# Oxford VR

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxford-vr

- Industry: Software
- Headquarters: Oxford, UK
- Website: www.ovrhealth.com
- Total disclosed funding: $15M
- Latest round: Series A (Dec 12, 2019)
- Investors on record: 6

## About

Oxford VR Ltd. specializes in delivering advanced mental health solutions through immersive virtual reality technology, focusing on rehabilitation for addiction and various mental health disorders.Oxford VR Ltd. was founded in 2016 in Oxford, UK, and operates in the mental health and addiction treatment space. The company has undergone no significant pivots in its business strategy. It has successfully raised funding across three deals, with its latest being a Series A round on December 12, 2019, where it secured GBP 10 million led by Optum Ventures. The total amount raised by the firm is GBP 10 million, post-money valuation at GBP 22.79 million, with investors including GT Healthcare Capital Partners and Oxford Sciences Innovation.Ovr Health specializes in providing innovative mental health and addiction treatment solutions, focusing primarily on rehabilitation services such as alcohol and substance abuse recovery. Their core offerings include access to specialized treatment programs, therapeutic modalities involving approaches like ketamine therapy, and supportive resources tailored for individuals grappling with various addictions and mental health challenges. Ovr Health emphasizes emotional healing and family support, offering services designed to foster connection and resilience among families, operating in various geographical markets across the United States, particularly urban centers where the need for mental health services is high.Ovr Health generates revenue through a structured model that includes direct-to-consumer services and partnerships with healthcare providers. Clients typically enroll in comprehensive treatment programs, paying for services on a subscription basis or one-time fees for therapeutic sessions. Their services, including ketamine therapy and counseling, are priced according to treatment complexity and duration, appealing to a diverse clientele. The firm collaborates with healthcare institutions to provide integrated services that enhance patient outcomes while fostering ongoing partnerships.In December 2019, Oxford VR Ltd raised GBP 10 million in Series A funding led by Optum Ventures, with participation from Luminous Ventures and returning investors. This funding will be utilized to further develop their innovative mental health solutions and potentially expand into new markets. Their strategy includes targeting additional urban centers in the United States where the demand for mental health services is significant. The recent funding will support product development and the enhancement of their service offerings.

## Funding rounds

- Series A, Dec 12, 2019, $13M — Oxford Sciences Enterprises, GT Healthcare Capital Partners, Optum Ventures, Oxford University Innovation Limited, Luminous Ventures
- Seed, Jan 23, 2017, $1.4M — Force Over Mass Capital, Oxford Sciences Enterprises

## Investors

- Force Over Mass Capital (https://capitalatlas.ai/funds/force-over-mass-capital) — Seed
- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Seed, Series A
- GT Healthcare Capital Partners (https://capitalatlas.ai/funds/gt-healthcare-capital-partners) — Series A
- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series A
- Oxford University Innovation Limited — Series A
- Luminous Ventures — Series A